Linden Capital L.P. 13D and 13G filings for Revelation Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-31 3:31 pm Sale |
2022-12-31 | 13G | Revelation Biosciences, Inc. REVB |
Linden Capital L.P. | 43 3.000% |
-5 (-10.01%) |
Filing |
| 2022-01-19 7:14 pm Purchase |
2022-01-14 | 13G | Revelation Biosciences, Inc. REVB |
Linden Capital L.P. | 47 5.800% |
47 (New Position) |
Filing |